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Our laboratory has developed a method of particle exposure whereby anesthetized rats
intratracheally inhale, at a regulated breathing rate and pressure, an aerosolized test material. This
method is capable of delivering considerable doses in a short time period and, unlike the
commonly used method of intratracheal instillation, does so with an even particle distribution
throughout the lung. Early studies comparing the response of male Fischer 344 rats exposed to
TiO2 particles of two differing primary particle sizes showed that at similar particle doses animals
exposed by the two methods showed differences in response, as measured by bronchoalveolar
lavage (BAL) parameters. Building on this, we sought to study the roles that macrophage
inflammatory protein-2 (MIP-2) and tumor necrosis factor alpha (TNF-a), two cytokines thought
to have proinflammatory roles in the lung, may play in the differences observed. Increases in
MIP-2 protein levels in the lavaged cells, but not the supernatant, were observed in those groups
where increased polymorphonuclear cells (PMN) in the lung lavage were found, but not in those
where no increase in PMN levels was observed. BAL TNF-a levels, measured by enzyme-linked
immunosorbent assay, showed no apparent correlation with cellular or biochemical BAL
parameters for either particle size or dosing method. Increases in immunocytochemical staining
for TNF-a, compared to unexposed controls, were observed in several particle-exposed groups.
Thus, it appears that increased BAL MIP-2 protein levels, but not TNF-a, correlate well with the
inflammatory response, as measured by PMN numbers in lavaged cells, for both exposure
systems. Environ Health Perspect 105(Suppl 5):1265-1271 (1997)
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Introduction
Intratracheal instillation is routinelyusedfor
exposure ofanimals to particles. It has the
advantages ofaccurate administration oftest
material veryrapidly to the lower respiratory
tract, bypassing upper respiratory tract
defenses and confining the dose to a small
volume, which reduces greatly the amount
ofequipment that must be decontaminated
after exposure to highly toxic, carcinogenic,
or radioactive materials. However, instilla-
tion is a less physiologic method ofexposure
than inhalation, and partides administered
by instillation may not behave like similar
particles in an aerosol. After instillation,
particles are increasingly deposited in the
basal regions ofthe lung (1), and have asig-
nificandy less homogeneous partide distrib-
ution than an inhalation exposure (2,3). It
has also been suggested that the use ofa
vehicle for suspending the particles may
alter the study results or sensitivity early
afteradministration (4).
However, standard inhalation systems,
either nose-only or whole-body chambers,
present difficulties when attempting to
achieve high lung particle burdens in a
This paper is based on a presentation at The Sixth International Meeting on the Toxicology of Natural and Man-
Made Fibrous and Non-Fibrous Particles held 15-18 September 1996 in Lake Placid, New York. Manuscript
received at EHF26 March 1997; accepted 3 July 1997.
The authors thank P. Wade-Mercer, N. Corson, Kiem Nguyen, Ro.Gelein, and L. Johnstone for technical
advice and assistance. These studies were supported by NIEHS grants ES04872, ES01247, and HL07216.
Address correspondence to Dr. M. Osier, Department of Environmental Medicine, University of Rochester
School of Medicine, 301 Elmwod Ave., Box EHSC, Rochester, NY 14642-0001. Telephone: (716) 275-8949.
Fax: (716) 256- 2631. E-mail: osierm@envmed.rochester.edu
Abbreviations used: BAL, bronchoalveolar lavage; ELISA, enzyme-linked immunosorbent assay; ITIH, intra-
tracheal inhalation; LPS, lipopolysaccharide; MIP-2, macrophage inflammatory protein-2; PBS, phosphate-
buffered saline; PMN, polymorphonuclear cells; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel
electrophoresis; TNF-a, tumor necrosis factoralpha.
short period oftime. The aerosol concen-
trations required for such exposures are
difficult to achieve and may not be well
tolerated by the animals as well as requir-
ing very large amounts oftest material and
the maintenance and postexposure cleaning
oflarge exposure chambers. Much ofthe
test material would be expected to deposit
in the upper respiratory tract or on the fur,
making ingestion of large amounts of
material a consideration. Additionally, par-
ticles that are respirable in humans may
not be so in a rodent inhalation system
(5,6), making their study in those models
moreproblematic.
Our laboratory has developed a method
ofintratracheal inhalation (ITIH) in rats
(7) in which the animals are ventilated at a
constant rate with an aerosol oftest mater-
ial. This system has the advantages ofan
intratracheal administration, such as elimi-
natingdeposition on skin and fur, bypassing
upper respiratory tract defenses, including
nasal filters for larger particles, and direct
deposition ofpartides in the lower respira-
tory tract. However, it is an inhalation sys-
tem and would be expected to deposit
partides in a homogeneous pattern similar
to that in other inhalation systems. We have
observed this to be the case with our ITIH
methodology, as will be detailed in a future
report. ITIH is also a closed system that
allows for the filtration and removal of
potentiallyhazardous or radioactive particles
before exhaust, thus greatly facilitating
cleaninganddecontamination procedures.
We previously observed differences in
bronchoalveolar lavage (BAL) parameters in
rats after exposure by ITIH or instillation
to two different sizes oftitanium dioxide:
fine and the more reactive ultrafine TiO2.
Animals exposed by ITIH showed a
decreased response in both persistence and
severity (Osier et al., unpublished data). As
several reports have linked events in the
inflammatory process to the production of
a number ofsoluble cytokines or chemo-
kines, we elected to investigate the role that
two ofthese-macrophage inflammatory
protein-2 (MIP-2) and tumor necrosis fac-
tor alpha (TNF-a)-played in the differ-
ences in response to particles that we
observed between intratracheal instillation
and intratracheal inhalation exposures.
MIP-2 is abasic, heat-stable, single-chain
protein with an approximate molecular
weight of6 kD. It is chemotactic for neu-
trophils but does not induce an oxidative
burst (8). It is mitogenic for epithelial cells
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but not for fibroblasts (9). mRNA for
MIP-2 has been demonstrated in macro-
phages, neutrophils, fibroblasts, and epithe-
lial cells (10-11). MIP-2 expression has
been reported after exposure to dusts (11),
lipopolysaccharide (LPS) (10), and other
inflammatory stimuli (12). As a result of
these studies and others, MIP-2 is believed
to play an important role in regulating
inflammatory responses within the lung.
TNF-a is a 17-kD (by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis
[SDS-PAGE]) protein with a wide variety
ofbiological activities. mRNA for TNF-a
has been reported in macrophages, neu-
trophils, fibroblasts, and epithelial cells
(10-11). TNF-a activity or mRNA expres-
sion has been reported in response to vari-
ous stimuli, including dusts (13), LPS (10),
and other inflammatory stimuli (14).
Antibodies to TNF-a ameliorate the fibrotic
response seen after silica exposure (15) as
well as decreasing tissue injury during
endotoxic shock (16). TNF-a also pro-
motes neutrophil adhesion (17) and induc-
tion of other cytokines such as MIP-1,
MIP-2, interleukin-l1, interleukin-6, and
interleukin-8 (11,16).
The present study investigates the
roles that TNF-a and MIP-2 may play
in the observed differences in BAL para-
meters, specifically neutrophil influx. It
was our hypothesis that alterations in
protein concentrations of these cytokines
would correspond to changes in BAL
neutrophil numbers.
Methods
Animals
Specific pathogen-free male Fischer 344
rats weighing 175 to 225 g were group
housed in wire-bottom cages. Animals were
fed Purina Laboratory Chow and water
adlibitum.
SelectionofParticles
In this study, two types oftitanium dioxide
were used. The first had a mean primary par-
ticle size of0.25 pm and will be referred to
as fine TiO2 (Fisher Scientific, Springfield,
NJ). The second had a mean primary parti-
cle size of approximately 0.021 pm and
will be referred to as ultrafine TiO2
(Degussa A.G., Frankfurt am Main,
Germany). Both particle types were ofthe
anatase crystalline form.
Intratcheal InhalatonExposures
Intratracheal inhalation exposures were
performed as previously reported by our
laboratory (7). Briefly, animals were
anesthetized with halothane and intubated
intratracheally with a modified 14-gauge
cannula. The open end ofthe cannula was
attached to a port on the inhalation appa-
ratus such that an airtight seal was formed.
The animals were ventilated at a frequency
of30 breaths/min (1.5-sec inhalation, 0.5-
sec exhalation) at a maximum inhalation
pressure of 15 cm H20 with an aerosol of
either water (sham-exposed)) or test mater-
ial. A schematic ofthe apparatus is shown
in Figure 1.
TiO2 aerosols were generated from a
sonicated aqueous suspension using a
Lovelace nebulizer, and dried through a
drying tube. Aerosols had mass median
aerodynamic diameter ranges from 1.0 to
1.2 and Fgvalues of 1.6 to 2.2. Target con-
centration was 125 mg/mi3. Concentration
was monitored with a light-based particle
sensor connected to a chart recorder.
Additional material was added as needed to
the nebulizer cup through a custom-
installed inlet, allowing either water or par-
ticle suspension to be added as required.
Halothane (0.75% final concentration) was
used to maintain anesthesia during expo-
sure. Animals were placed on a heating pad
to prevent a fall in body temperature during
exposure. Exposure duration was 2 hr. After
exposure the tracheal catheter was removed,
and the animals were allowed to recover on
a heating pad, usually 5 to 20 min, before
Halothane
generator
Magnehelic
Compressed +
air
being returned to their cages. Animals
(three per group) were sacrificed on days 0,
1, 3, and 7 postexposure.
IntrtrachealInstllation Exposures
Animals were anesthetized with halothane
and a small catheter, attached to a 1-ml
syringe, was inserted into the trachea via a
modified otoscope. An amount ofparticles
equivalent to that present in the day 0
ITIH group (500 pg fine TiO2, 750 pg
ultrafineTiO2) was instilled suspended in a
volume of0.2 ml saline. TiO2 in the lungs
of the ITIH groups was determined by
chemical analysis, as described below. This
led to lung burdens on day 1 postexposure
that were slightly, but not significantly,
lower than those ofanimals receiving parti-
cles by ITIH. Particle suspensions were
placed in an ultrasonic bath for 10 min
before instillation to ensure an even sus-
pension. Animals were allowed to recover,
then returned to their cages. Groups of
animals (three per group) were sacrificed
on days 0, 1, 3, and 7 postexposure.
TissueTitanium Dioxide
Determination
Analysis was performed by atomic emission
spectroscopy using techniques previously
described in our laboratory (18). Samples
of lung tissue, aliquots oflavage super-
natant, and lavage cell pellets were dried
overnight, ashed, and then fused in platinum
Figure1.Schematic oftheITIHexposuresystem.
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crucibles with a 2:1 (w/w) mixture of
sodium carbonate and sodium borate. The
melt was dissolved in 7% (v/v) sulfuric
acid; titanium content was determined by
plasma atomic emission spectroscopy, read-
ing emission at the 334.91-nm emission
line. Titanium dioxide concentration was
calculated from the titanium content.
Bronchoalveolar lvage
Bronchoalveolar lavage (BAL) was per-
formed as previously described in our
laboratory (19). Briefly, animals were anes-
thetized with sodium pentobarbital and sac-
rificed by exsanguination via the carotid
artery. The trachea was cannulated and the
trachea, heart, and lungs removed en bloc.
The heart and fascia were removed, and
the lungs lavaged 10 times with 5 ml each
ofsterile saline at room temperature. The
first two washes were pooled, as were the
final eight. The washes were centrifuged at
400 xgfor 10 min at 4°C in a swinging-
bucket centrifuge. The supernatant from the
first two washes was frozen in aliquots and
saved for later analysis, and the cells from all
washes were pooled and resuspended in
saline to 15 ml finalvolume.
MeasurementofCytokineLevels
Aliquots ofBAL supernatant and lysed cell
pellet were analyzed for MIP-2 and TNF-a
protein levels by enzyme-linked immuno-
sorbent assay (ELISA) using commercially
available, rat-specific kits (BioSource,
Camarillo, CA). Because of low TNF-a
levels in most samples, the samples were
concentrated by lyophilization prior to
TNF-az analysis.
Immunohlstocnemical
StainingorTNF-ax
Exposed animals were sacrificed, and the
lungs perfused with sterile, room-tempera-
ture saline through the pulmonary artery.
The lungs were inflated with and fixed in
10% neutral-buffered formalin and embed-
ded in paraffin. Five micron-thick sections
were cut onto Superfrost slides (VWR
Scientific, San Francisco, CA) and dried in
a 60°C oven overnight.
Slides were rehydrated through xylene
and alcohols to phosphate-buffered saline
(PBS), then blocked with normal serum for
30 min at room temperature. Slides were
washed in PBS, then incubated with anti-
TNF-a antibody at a 1:50 dilution for 90
min at room temperature. The slides were
again washed in PBS and secondary anti-
body from the Vectastain staining kit
(Vector Labs, Burlingame, CA) was added
for 60 min at room temperature. Slides were
washed and 10 pg/ml fluorescein avidin B
(Vector Labs) added for 30 min in the dark
at room temperature. Slides were washed in
distilledwater in the dark, then coverslipped
withVectashield mountingmedium (Vector
Labs) and stored in the dark at 40C until
examined. Examination was performed in a
blinded fashion, and a qualitative rating
scalewas used to rank thesamples.
SttisticalAnalysis
Data were analyzed with the SigmaStat
statistics package Uandel). An analysis of
variance was performed, and Tukey's test
used to determine significance ofindividual
groups. Comparisons were made between
unexposed, sham-exposed, and particle-
exposed groups as well as between similarly
exposed groups at different time points. A
group was considered significant if the
p value was less than 0.05.
Results
LungTi02Burdens
The TiO2 lung burdens of the ITIH-
exposed animals immediately after expo-
sure were 490 ± 119 pg for the fine TiO2
and 765 ± 81 pg for the ultrafine TiO2.
These levels were used to determine the
instilled doses. Lung TiO2 content on day
1 for the fine TiO2 particles was 393 ±44
pg and 498 ± 59 pg for the instilled and
inhaled groups, respectively. These levels
were not significantly different from
each other (p=0.07). The burdens for the
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ultrafine TiO2 groups were 559± 35 pg
for the instilled group and 690 ± 133 pg
for the inhaled group, which also were
not significantly different from each
other (p=0.175).
PMN Numbers in BALPellet
Total numbers of polymorphonuclear
leukocytes (PMN) in the lavage cell pellet
are shown in Figure 2. No changes were
seen following sham exposure. Exposure to
fine TiO2 resulted in an increased number
of PMNs only after instillation, and then
only at the day 1 time point. No significant
changes in PMN number were seen after
intratracheal inhalation offineTiO2. When
ultrafine TiO2 was given by intratracheal
inhalation, an increase in PMN numbers
was seen on day 1, which decreased to con-
trol levels by day 3 postexposure. Following
instillation of"ultrafine" TiO2, a significant
increase in PMN number was seen on days
1, 3, and 7 postexposure. This increase was
also significantly elevated when compared
to the ultrafine group, which was exposed
by intratracheal inhalation.
Macrophage Inflammatory
ProteinLe
MIP-2 protein levels in the lavage
supernatant, measured by ELISA, are
shown in Figure 3A. Decreases in immuno-
reactive MIP-2 were seen on days 0, 1, and
3 for those animals exposed to ultrafine
TiO2 by intratracheal inhalation, with a
decrease observed for those animals
exposed to ultrafine TiO2 by instillation
___ Control
_ ITIHH20
_ Insdillfine
**F _ ITIHfine
_Insdill uft.ine
T _ ITIHuftrafine
*
o 1
Day0 DayI Day3 Day7
Figure 2. PMN numbers in BAL cell pellet. Data are mean ±SD. *Significantly different (p<0.05) from unexposed
animals. **Significantly differentfrom unexposed animals and ITIH-exposed group of same particle type.
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Figure 4.TNF-a protein levels in BAL supernatant(A) and cell pellet(B). Data are mean ± SD.
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only at the day 1 time point. No other
significant changes were observed in the
lavage supernatant.
Figure 3B shows MIP-2 levels in the
lysed lavage cell pellet. An increase in MIP-2
concentration was observed in animals
exposed to fineTiO2 byinstillation, but this
difference was not significant. No other
changes in pellet MIP-2 levels were observed
in animals exposed to fine TiO2. Animals
exposed to ultrafine TiO2 by instillation
showed significant increases in pellet MIP-2
protein levels on days 1, 3, and 7 postexpo-
sure. After intratracheal inhalation ofultra-
fine TiO2, increased pellet MIP-2 levels
were seen onlyatday 1 postexposure.
TumorNecrsis FactorAlphaLvels
TNF-a levels in the lavage supernatant
and cell pellet are shown in Figure 4A, B.
No significant changes were observed in
either fraction at any time point, particle
type, or exposure method. Recovery in
samples spiked with TNF-ax and following
concentration by lyophilization was
greater than 95%.
As shown in Figure 5A, animals intra-
tracheally instilled with saline showed very
low amounts of TNF-a at day 1 when
lung sections were examined immuno-
cytochemically. Similarly, at day 1, ani-
mals sham exposed by ITIH showed little
TNF-a immunoreactivity (Figure 5B).
However, animals receiving ultrafine TiO2
by instillation (Figure 5C) or ITIH
(Figure 5D) showed increased TNF-a
activity. Smaller increases were seen in fine
TiO2-exposed animals.
The results of our TNF-a immuno-
cytochemical studies are summarized quali-
tatively in Table 1. No response was seen
in sham-instilled animals at any time point
observed. Sham-exposed ITIH animals
showed an increase in TNF-a staining on
day 0, which decreased to undetectable by
day 3. Animals exposed to fine TiO2
showed little staining at any time point or
exposure method examined, with staining
confined predominantly to particle-con-
taining macrophages. Animals instilled
with ultrafine TiO2 showed increased
staining on day 1, which rapidly decreased
by day 3. By contrast, animals exposed to
ultrafine TiO2 by ITIH showed significant
staining at all time points examined, with
slightly less staining on day 1 than at other
time points.
Discussion
Using the two different methods of intra-
tracheal inhalation and intratracheal instil-
lation, we administered TiO2 to rats. The
ITIH animals had slightly higher dust lev-
els in their lungs on day 1 postexposure,
although the lung burdens achieved using
ITIH and instillation were not significantly
different. In spite of the slightly greater
lung burden in the ITIH animals, the
ITIH-exposed animals in general showed a
lesser response than the instillation-exposed
animals for each particle type.
Our results demonstrate increases in
MIP-2 protein levels within the BAL pellet
in those groups where increased PMN
influx was observed. As MIP-2 is chemo-
tactic for neutrophils (8), this finding is
not surprising. However, PMNs express
mRNA for MIP-2 (10). This raises the
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Table 1. TNF-a protein levels, as measured by
immunocytochemistry.
Group Day 0 Day 1 Day 3 Day7
Instilled saline - - ND ND
ITIHH20 e (+) - ND
Instilled fine TiO2 - (+) +
ITIH fine TiO2 - + ND ND
Instilled ultrafine TiO2 - + (+) -
ITIH ultrafine TiO2 +++ ++ +++ +++
ND, not done. Samples were rated from - to ++++,
with ++++ being the highest rating.
question ofwhether the PMNs were a
major source ofthe increased MIP-2 levels
we observed or merely a result of the
increased MIP-2 levels seen. Further
studies using immunocytochemistry should
help us address this issue.
Previous studies have suggested an
important role forTNF-a in the inflamma-
tory process, with alterations in TNF-a
mRNA or activity seen as early as 0.7 hr
after inhalation ofLPS, a potent inducer of
inflammation (20), as well as during dust-
induced inflammation (15-17). Therefore,
a surprising resultofthese studies was alack
ofobserved changes in TNF-a protein lev-
els, measured by ELISA, in either the lavage
supernatant or cell pellet. However, the
more sensitive method of immunocyto-
chemistry clearly shows increased TNF-ax
levels in several lung sections. It is interest-
ing that increases in TNF-a staining did
not appear to correlate with inflammatory
cell influx, as less significant changes were
seen in animals instilled with particles
(more inflammation) than in those exposed
by ITIH (less inflammation). However,
macrophages that had phagocytized parti-
cles often showed staining for TNF-a, even
in those animals where few other responses
were seen. Increased staining was also evi-
dent in the sham-exposed ITIH group of
animals, which suggests that ventilation of
the animals is sufficient to provoke TNF-ax
synthesis. Useful future studies might
include a) immunocytochemical staining
on samples ofBAL cell pellet to investigate
the discrepancy between BAL ELISA analy-
sis and TNF-a staining on whole lung sec-
tions, and b) further investigation ofthe
decreased TNF-a staining in ultrafine
TiO2-instilled animals compared to the
ITIH-exposed animals, in which a lessened
BAL response was seen.
The PMN response, which was paral-
leled by increases in MIP-2 in the BAL cell
pellet, appears to indicate that, for both
sizes ofTiO2 particles, an instilled dose
will elicit a more persistent and/or severe
response than a similar amount ofparticles
administered by intratracheal inhalation.
Several reasons could account for these
differences. A number of investigators
(1-4) have demonstrated differences in
particle distribution or homogeneity of
exposure between instillation and inhala-
tion methods. The heterogeneous distribu-
tion of particles after an instilled dose
would be expected to create areas ofhigh
and low concentration within the lung.
These focal areas ofhigh particle burden
could be expected to react more strongly
than in a situation in which the same dose
was more evenly distributed throughout
the lung.
Differences in the dose rate between
instillation and intratracheal inhalation may
also play a role in the differences in PMN
response observed. Ferin et al. (21) reported
significant differences in interstitialization of
particles administered by intratracheal instil-
lation or inhalation, and claimed that the
difference in dose delivery rates was a deci-
sive factor. However, Henderson et al. (22)
found no differences in BAL parameters
among animals exposed by inhalation to
carbon black at different exposure rates
resulting in similar particle burdens.
Determination ofthe respective roles dose
rate, dose, and particle distribution that play
on the effects seen in this system will require
furtherstudies.
Our studies have shown that increases
in MIP-2 levels in the BAL cell pellet, but
not in the supernatant, appear to correlate
with BAL PMN response. TNF-ax levels,
in either the BAL pellet or supernatant, did
not show any significant changes at any
exposure method or time point, nor did
changes in TNF-a immunocytochemical
staining appear to correlate with inflamma-
tory cell influx. As with other BAL parame-
ters, pellet MIP-2 levels seem to be greater
in persistence and value after an instilled
dose than after an intratracheal inhalation
of a similar dose of the same particles.
Further study ofthese differences may give
us information about the role ofparticle
distribution and/or dose rate in particle
effects, and the role these mediators may
play in the process.
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